MYGN insider receives 39,370 shares in stock awards
By AlphaYouPublished Form 4
Fox Jennifer Lynne
Reporting filer
Fox Jennifer Lynne reported 39,370 shares of Common Stock in MYRIAD GENETICS INC as grants or awards dated 2026-11-01. The Form 4 was disclosed on Nov 3, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Fox Jennifer Lynne | 2026-11-01 | A | Grant or award | 39370 | 0 | 345,334 | 2 days | Filed terms
|
Common Stock
- Owner
- Fox Jennifer Lynne
- Date
- 2026-11-01
- Code
- A
- Action
- Grant or award
- Quantity
- 39370
- Price
- 0
- Following holdings
- 345,334
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 39370
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 345334
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Fox Jennifer Lynne: Chief Legal & Corp Strategy.
- F1: Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
Original sources
Prepared automatically from public filing data. Report a correction.